HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
HTR1A
5-hydroxytryptamine receptor 1A
Chromosome 5 · 5q12.3
NCBI Gene: 3350Ensembl: ENSG00000178394.5HGNC: HGNC:5286UniProt: A8K5W4
401PubMed Papers
21Diseases
35Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Receptor
RESEARCH IMPACT
Highly Studied
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
receptor-receptor interactionG protein-coupled serotonin receptor activityGi/o-coupled serotonin receptor activityG protein-coupled receptor signaling pathwaymajor depressive disorderschizophreniabipolar disorderanxiety disorder
✦AI Summary

HTR1A encodes the 5-hydroxytryptamine receptor 1A, a G-protein coupled receptor that binds serotonin and mediates inhibitory neurotransmission 1. The receptor couples to Gi/Go proteins, inhibiting adenylyl cyclase activity and activating phosphatidylinositol-calcium signaling pathways that regulate intracellular calcium release 1. HTR1A plays crucial roles in regulating serotonin and dopamine metabolism, affecting neural activity, mood, and behavior 2. The gene shows significant clinical relevance across multiple disorders. Genetic polymorphisms, particularly rs6295, have been associated with suicidal behavior risk, though meta-analyses show conflicting results 34. HTR1A variants also influence treatment response to antipsychotics with 5-HT1A partial agonism in schizophrenia patients 5. Expression studies reveal altered HTR1A levels in autism spectrum disorders, with the gene showing undetectable expression in ASD samples compared to controls 6. Additionally, HTR1A contributes to portal hypertension by mediating portal vein smooth muscle contraction, suggesting therapeutic potential for liver disease complications 7. The receptor's diverse functions highlight its importance in neuropsychiatric disorders and vascular pathophysiology.

Sources cited
1
HTR1A is a GPCR that couples to Gi/Go proteins and regulates calcium signaling
PMID: 33762731
2
HTR1A regulates serotonin/dopamine metabolism and affects mood and behavior
PMID: 20363322
3
rs6295 polymorphism associated with increased suicidal behavior risk
PMID: 36214900
4
Meta-analysis showing no association between HTR1A and suicidal behavior
PMID: 22392387
5
HTR1A variants influence antipsychotic treatment response in schizophrenia
PMID: 25822479
6
HTR1A expression undetectable in autism spectrum disorder samples
PMID: 26782176
7
HTR1A mediates portal vein contraction and portal hypertension
PMID: 38906512
Disease Associationsⓘ21
major depressive disorderOpen Targets
0.64Moderate
schizophreniaOpen Targets
0.62Moderate
bipolar disorderOpen Targets
0.61Moderate
anxiety disorderOpen Targets
0.61Moderate
autismOpen Targets
0.60Moderate
AgitationOpen Targets
0.58Moderate
bipolar I disorderOpen Targets
0.58Moderate
depressive disorderOpen Targets
0.57Moderate
psychosisOpen Targets
0.56Moderate
Tourette syndromeOpen Targets
0.54Moderate
Alzheimer diseaseOpen Targets
0.53Moderate
AnxietyOpen Targets
0.52Moderate
obesityOpen Targets
0.52Moderate
generalized anxiety disorderOpen Targets
0.51Moderate
autism spectrum disorderOpen Targets
0.51Moderate
post operative nausea and vomitingOpen Targets
0.49Moderate
menstrual cycle-dependent periodic feverOpen Targets
0.47Moderate
migraine disorderOpen Targets
0.47Moderate
cardiovascular diseaseOpen Targets
0.46Moderate
gastrointestinal diseaseOpen Targets
0.46Moderate
Periodic fever, menstrual cycle-dependentUniProt
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets35
ADOPRAZINEPhase I
Dopamine D2 receptor antagonist
schizophrenia
ALVERINEApproved
Hepatocyte nuclear factor 4-alpha activator
gastrointestinal disease
AMISULPRIDEApproved
Serotonin (5-HT) receptor antagonist
Nausea and vomiting
ARIPIPRAZOLEApproved
Serotonin 2a (5-HT2a) receptor antagonist
ARIPIPRAZOLE LAUROXILApproved
Serotonin 2a (5-HT2a) receptor antagonist
schizophrenia
BEFIRADOLPhase II
Serotonin 1a (5-HT1a) receptor agonist
movement disorder
BIFEPRUNOXPhase III
Serotonin 1a (5-HT1a) receptor partial agonist
schizophrenia
BREXPIPRAZOLEApproved
Serotonin 2a (5-HT2a) receptor antagonist
schizophrenia
BUSPIRONEApproved
Serotonin 1a (5-HT1a) receptor partial agonist
anxiety disorder
BUSPIRONE HYDROCHLORIDEApproved
Serotonin 1a (5-HT1a) receptor partial agonist
anxiety disorder
DEXFENFLURAMINEApproved
Serotonin (5-HT) receptor agonist
obesity
DEXFENFLURAMINE HYDROCHLORIDEUNKNOWN
Serotonin (5-HT) receptor agonist
DU 125530Phase II
Serotonin 1a (5-HT1a) receptor antagonist
mood disorder
ERGOLOID MESYLATESApproved
Serotonin 1a (5-HT1a) receptor agonist
cardiovascular disease
GEPIRONEApproved
Serotonin 1a (5-HT1a) receptor agonist
major depressive disorder
GEPIRONE HYDROCHLORIDEApproved
Serotonin 1a (5-HT1a) receptor agonist
major depressive disorder
GSK163090Phase II
Serotonin 1a (5-HT1a) receptor antagonist
anxiety disorder
LECOZOTANPhase II/III
Serotonin 1a (5-HT1a) receptor antagonist
Alzheimer disease
LECOZOTAN HYDROCHLORIDEPhase II/III
Serotonin 1a (5-HT1a) receptor antagonist
Cognitive impairment
METHYSERGIDEApproved
Serotonin 2c (5-HT2c) receptor antagonist
migraine disorder
NALUZOTANPhase III
Serotonin 1a (5-HT1a) receptor agonist
Anxiety
OSEMOZOTANPhase II
Serotonin 1a (5-HT1a) receptor agonist
mood disorder
PARDOPRUNOXPhase III
Serotonin 1a (5-HT1a) receptor agonist
Parkinson disease
PICLOZOTANPhase II
Serotonin 1a (5-HT1a) receptor agonist
coronary artery disease
ROBALZOTANPhase II
Serotonin 1a (5-HT1a) receptor antagonist
anxiety disorder
SARIZOTANPhase III
Dopamine D3 receptor agonist
movement disorder
SARIZOTAN HYDROCHLORIDEPhase II
Dopamine D3 receptor agonist
Parkinson disease
ULOTARONTPhase III
Serotonin 1a (5-HT1a) receptor agonist
schizophrenia
VILAZODONEApproved
Serotonin transporter inhibitor
major depressive disorder
VILAZODONE HYDROCHLORIDEApproved
Serotonin transporter inhibitor
VORTIOXETINEApproved
Serotonin 1a (5-HT1a) receptor agonist
major depressive disorder
VORTIOXETINE HYDROBROMIDEApproved
Serotonin 1a (5-HT1a) receptor agonist
XALIPRODENPhase III
Serotonin 1a (5-HT1a) receptor agonist
Alzheimer disease
ZIMELDINEApproved
Serotonin (5-HT) receptor antagonist
major depressive disorder
ZIMELDINE HYDROCHLORIDEUNKNOWN
Serotonin (5-HT) receptor antagonist
Related Genes
GNG13Protein interaction100%GNG4Protein interaction100%GNG2Protein interaction100%GNG7Protein interaction100%BDNFProtein interaction97%SLC6A4Protein interaction97%
Tissue Expression6 tissues
Brain
100%
Ovary
12%
Bone Marrow
2%
Liver
0%
Heart
0%
Lung
0%
Gene Interaction Network
Click a node to explore
HTR1AGNG13GNG4GNG2GNG7BDNFSLC6A4
PROTEIN STRUCTURE
Preparing viewer…
PDB8PJK · 2.40 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.96LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.64 [0.44–0.96]
RankingsWhere HTR1A stands among ~20K protein-coding genes
  • #729of 20,598
    Most Researched401 · top 5%
  • #88of 1,025
    FDA-Approved Drug Targets17 · top 10%
  • #9,055of 17,882
    Most Constrained (LOEUF)0.96
Genes detectedHTR1A
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
Association between the HTR1A rs6295 gene polymorphism and suicidal behavior: an updated meta-analysis.
PMID: 36214900
Eur Arch Psychiatry Clin Neurosci · 2023
1.00
2
No association between the HTR1A gene and suicidal behavior: a meta-analysis.
PMID: 22392387
Braz J Psychiatry · 2012
0.90
3
Attention-deficit/hyperactive disorder updates.
PMID: 36211978
Front Mol Neurosci · 2022
0.80
4
Combined HTR1A/1B methylation and human functional connectome to recognize patients with MDD.
PMID: 36150307
Psychiatry Res · 2022
0.70
5
Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-by-environment interaction for panic disorder.
PMID: 23635830
Neuropsychobiology · 2013
0.64